Neupogen, Filgrastim

Bookmark

Add to MyYahoo RSS

Neupogen, Filgrastim News

News on Neupogen, Filgrastim (generic) continually updated from thousands of sources around the net.

Jan 14, 2014 | Hispanic Business

Neumedicines Spotlights HemaMax Study Results in Presentation at Biotech Showcase Conference

During the Neumedicines presentation, Dr. Basile will discuss results from a blinded, randomized study showing that a single, low- dose of HemaMax administered subcutaneously to non-human primates at 24-25 hours post exposure to lethal radiation significantly increased survival compared with control.

Comment?

Related Topix: Medicine, Oncology

Thu Jan 09, 2014

Hispanic Business

Neumedicines to Feature HemaMax Study Results in Presentation at Biotech Showcase Conference

During the Neumedicines presentation, Dr. Basile will discuss results from a blinded, randomized study showing that a single, low-dose of HemaMaxTM administered subcutaneously to non-human primates at 24-25 hours post exposure to lethal radiation significantly increased survival compared with control.

Comment?

Related Topix: Medicine, Oncology

Wed Jan 08, 2014

Customer Interaction Solutions

Neumedicines' Study Shows HemaMax, Not Neupogen (G-CSF), Improves...

Neumedicines Inc., a privately held company developing therapies based on interleukin-12 as a radiation medical countermeasure and as a hematopoietic immunotherapeutic for use in cancer patients, today announced results from a blinded, randomized, placebo-controlled study that demonstrate a significant increase in survival in non-human primates ... (more)

Comment?

Related Topix: Medicine, Centers for Disease Control and Prevention

•••
•••
•••
•••
•••
•••
•••
•••